Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Pharmigene, Inc. (7595) Financial Statements

Pharmigene, Inc. Financial Overview

Pharmigene, Inc.'s market cap is currently NT$413.81M. The company's EPS TTM is NT$-1.04; its P/E ratio is -8.07; Pharmigene, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 199.89MNT$ 116.53MNT$ 132.71MNT$ 133.80MNT$ 129.35M
Gross ProfitNT$ 38.91MNT$ 41.47MNT$ 42.54MNT$ 44.73MNT$ 46.05M
Operating IncomeNT$ -54.96MNT$ -81.28MNT$ -59.19MNT$ -44.45MNT$ -22.73M
EBITDANT$ -29.26MNT$ -46.75MNT$ -41.85MNT$ -22.01MNT$ -6.83M
Net IncomeNT$ -73.00MNT$ -82.86MNT$ -72.65MNT$ -42.72MNT$ -23.43M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 87.46MNT$ 160.64MNT$ 181.76MNT$ 195.59MNT$ 239.09M
Total AssetsNT$ 988.37MNT$ 1.00BNT$ 1.05BNT$ 384.27MNT$ 419.12M
Total DebtNT$ 655.05MNT$ 616.49MNT$ 571.10MNT$ 9.43MNT$ 14.74M
Net DebtNT$ 598.57MNT$ 524.14MNT$ 502.56MNT$ -67.43MNT$ -89.55M
Total LiabilitiesNT$ 709.93MNT$ 654.08MNT$ 602.85MNT$ 44.52MNT$ 36.90M
Stockholders' EquityNT$ 278.43MNT$ 349.06MNT$ 444.10MNT$ 339.75MNT$ 382.22M
Cash Flow
Free Cash FlowNT$ -76.39MNT$ -111.80MNT$ -745.35MNT$ -34.05MNT$ -37.98M
Operating Cash FlowNT$ -66.99MNT$ -44.82MNT$ -77.54MNT$ -23.47MNT$ -19.30M
Investing Cash FlowNT$ -6.02MNT$ 21.10MNT$ -657.43MNT$ 4.90MNT$ -82.28M
Financing Cash FlowNT$ 37.24MNT$ 47.28MNT$ 726.65MNT$ -9.18MNT$ -6.89M

Currency in TWD

Pharmigene, Inc. Earnings and Revenue History

-120M0120M240M-75 %-50 %-25 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Pharmigene, Inc. Liabilities to Assets

0400M800M1.2B0 %30 %60 %90 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Pharmigene, Inc. Cash Flow

-750M-500M-250M0250M500M750M1B201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Pharmigene, Inc. Forecast EPS vs Actual EPS

Earnings >